Navigation Links
UCLA paper examines how one disease may prevent another

The knowledge that one disease may prevent the onset of another is not new. For example, the discovery that cowpox vaccines can prevent smallpox dates back to 1798.

Dr. E. Richard Stiehm, a professor of pediatrics at the Mattel Children's Hospital at UCLA, researched examples throughout medical history of ways that one disease prevents another.

His findings suggest that genetic, infectious and metabolic influences should be considered when looking for treatments, particularly in regard to HIV/AIDS.

"Clinical observations of disease-versus-disease interactions have led to an understanding of the mechanisms of several diseases," Stiehm said. "In turn, these observations have led to the development of vaccines, therapeutic antibodies, medications and special diets."

Detailed in the January 2006 issue of Pediatrics, the official peer-reviewed journal of the American Academy of Pediatrics, Stiehm's research illustrated 12 disease pairs, reviewed their therapeutic implications and suggested additional applications.

A few of the pairings that Stiehm described include:

  • Sickle cell disease and malaria. In 1948, British biologist J.B. Haldane proposed that malaria was an evolutionary force for selecting malaria-resistant genes. He suggested that those carrying the gene for sickle cell anemia were better able to survive in malaria-infected areas.
  • Leprosy patients have severe immune defects and cutaneous anergy -- an inability to respond to skin testing. They hardly ever get psoriasis, a skin disorder. Starvation was used since biblical times for the treatment of seizures, which were believed to be demons. A 1924 discovery showed that a diet rich in fat and low in carbohydrates mimicked starvation by causing ketonemia and also controlled seizures. The ketogenic diet is still used today for cases of epilepsy resistant to medication.
  • During the 1994 winter of starvation when bread supplies to the children's hospital
    '"/>


Source:University of California - Los Angeles


Page: 1 2

Related biology news :

1. Rewind, please: Nature paper shows that cell division is reversible
2. Recycled paper and compost could both be key tools to control plant disease
3. Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry
4. McBride shows DNA detective work with paper-eating bacteria that glide
5. U of M researcher examines newly emerging deadly disease
6. A new study examines how shared pathogens affect host populations
7. New study examines how sense of smell affects mating and aggression in mice
8. New research examines genetics of successful aging
9. U of M study examines kidney stone prevention in astronauts
10. New research examines genetics of successful aging
11. Pooled data examines if SNPs add to breast cancer risk

Post Your Comments:
(Date:11/20/2009)...ed in the November 2009 issue of the journal GENE... how a family of genes (1-aminocyclopropane-1-carb...r production of ethylene. This gas affects many as...ays the foundation for future genetic manipulation... survive and thrive in difficult terrain, increase...
(Date:11/20/2009)...versity of Oklahoma researchers were sequencing th...me project. Today, the OU Advanced Center for Ge...l effort to sequence the tomato genome with a $7.5...ndation for plant genomics. , "The tomato has t... tomato and crop yields will improve quality of li...
(Date:11/20/2009)...gin of biological molecules like RNA and DNA is ho...rom simple precursors. Now, in a study appearing i...structed one of the earliest evolutionary steps ye...ubunits using nothing but warm water. , Many re...ological molecules present, before DNA and protein...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 1Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 3Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 4New Research Shows 3A Neurofeedback is an Evidence Based Treatment for ADHD 4729 1New Research Shows 3A Neurofeedback is an Evidence Based Treatment for ADHD 4729 2Study demonstrates the anti inflammatory properties of pine bark extract 51856 1Study demonstrates the anti inflammatory properties of pine bark extract 51856 2
...Glynn, a professor at the University of Miamis Ros...as been selected to receive the 2007-2008 Provosts...s extraordinary research and scholarly pursuits, a... continued research support. , This marks the sec... first introduced in 1996, will receive this honor...
...trogen runoff from urban and agriculture land-use ... processes for reducing this pollutant before it e... nationwide team of 31 ecologists, including two f...ems Center. , The findings, published in the Ma... of 72 streams in 8 regions across the U.S. and Pu...
...one of the worlds most endangered speciesa North I...al Zoo Bird House. Keepers had been incubating the...tion by the chicks father, carefully monitoring it...ick starts to break through the shell. The chick r... specially designed brooding box. , The box will...
Other Biology News:UM coral scientist Peter Glynn wins award for scholarly activity 2Increasing nitrogen pollution overwhelms filtering capability of streams 2Rare North Island brown kiwi hatches at the Smithsonian's National Zoo 2
(Date:11/19/2009)...Nov. 19 Dr. Mate Hidvegi, inventor...to a press release issued on November 17 by Biroph...aking false and self-serving statements about its ...idvegi stated from his office in Budapest, Hungary...emar does not apply to AveULTRA, www.aveultra.co...
(Date:11/19/2009)...ov. 19 Spherix Incorpora...y for diabetes therapy, and a provider of technica...lement, biotechnology and pharmaceutical companies...Meeting of Shareholders. ,, At the meeting, sha... elected the following members to the Board of Dir...
(Date:11/19/2009)...9 /PRNewswire/ - Aegera Therapeutics Inc. announce...mized Phase 2B study of AEG35156, a targeted antis...iple oncology indications. ,, The study, entitl...X-Linked Inhibitor of Apoptosis (XIAP) Antisense A...bine and Idarubicin in AML Following Failure of a ...
(Date:11/19/2009)...nSound is honored by latest award for revolutionar...CA (PRWEB) November 16, 2009 -- Popular Science Ma... hearing aid from InSound Medical a winner of its ...th category.    Chosen from th...eep in the hearing canal for up to four months whi...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
... Inc., a subsidiary of,Eisai Corporation of North ...ulti-centered Phase II study of its MORAb-009 mono...aluate MORAb-009, plus the chemotherapy drugs,peme...for patients with,mesothelioma. , The primary ...f MORAb-009,as combination therapy with the curren...
...ll/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: A...new Senior Secured Term Loan and Revolving Credit ...ranger, administrative agent and lender for both t...financing includes a delayed draw secured term loa...olving credit facility with a borrowing base deriv...
... the California Institute for Regenerative Medicin... Stemedica Cell Technologies, Inc. ("Stemedic...;D lab and corporate headquarters. , ...9 -- Leadership of the California Institute for Re... two part visit to Stemedica Cell Technologies, In...
Other Biology Technology:Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 2Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 4CIRM Completes Briefing Visit to Stemedica Cell Technologies 2CIRM Completes Briefing Visit to Stemedica Cell Technologies 3
Experion RNA StdSens Chips, 10 from Bio-Rad
MiniMACS Separation Unit from Miltenyi Biotec
Experion RNA HighSens Chips, 10 from Bio-Rad
...activated with carbonyl diimidazole chemistry that...e PS10 array contains the same binding chemistry a...hobic barrier coating. These arrays are 8 spot chi...ith one column of a standard 96-well microplate (9...
Biology Products: